Process View
A protein-lipid complex subunit organization process that results in the formation, disassembly, or alteration of a plasma lipoprotein particle. A plasma lipoprotein particle is a spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "plasma lipoprotein particle organization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| APOA1 | apolipoprotein A-I | 1.000 | ||
| ALB | albumin | 0.998 | ||
| HP | haptoglobin | 0.983 | ||
| APOC1 | apolipoprotein C-I | 0.914 | ||
| SNTB2 | syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) | 0.895 | ||
| APOE | apolipoprotein E | 0.850 | ||
| A2M | alpha-2-macroglobulin | 0.819 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.628 | ||
| APOC3 | apolipoprotein C-III | 0.571 | ||
| APOA2 | apolipoprotein A-II | 0.470 | ||
| APOC2 | apolipoprotein C-II | 0.287 | ||
| FGA | fibrinogen alpha chain | 0.175 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.153 | ||
| TTR | transthyretin | 0.131 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.072 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.059 | ||
| RPL18A | ribosomal protein L18a | 0.055 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.050 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.038 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.035 | ||
| PLTP | phospholipid transfer protein | 0.035 | ||
| STX12 | syntaxin 12 | 0.034 | ||
| LDLR | low density lipoprotein receptor | 0.029 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.025 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.024 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.023 | ||
| FAM83C | family with sequence similarity 83, member C | 0.023 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.019 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.016 | ||
| PDCD4 | programmed cell death 4 (neoplastic transformation inhibitor) | 0.016 | ||
| AES | amino-terminal enhancer of split | 0.016 | ||
| DNTT | deoxynucleotidyltransferase, terminal | 0.016 | ||
| KRT16 | keratin 16 | 0.016 | ||
| ELANE | elastase, neutrophil expressed | 0.015 | ||
| FAM203A | family with sequence similarity 203, member A | 0.015 | ||
| SCARB1 | scavenger receptor class B, member 1 | 0.014 | Mouse | |
| LBP | lipopolysaccharide binding protein | 0.014 | ||
| DSE | dermatan sulfate epimerase | 0.014 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.013 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.013 | ||
| LIPC | lipase, hepatic | 0.012 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.012 | ||
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.012 | ||
| RIBC2 | RIB43A domain with coiled-coils 2 | 0.011 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.011 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.011 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.011 | ||
| ECSIT | ECSIT homolog (Drosophila) | 0.011 | ||
| MAPT | microtubule-associated protein tau | 0.011 | ||
| MTTP | microsomal triglyceride transfer protein | 0.010 |